Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH
- PMID: 15705082
- DOI: 10.1111/j.1464-410X.2005.05341.x
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH
Abstract
Objectives: To determine the prevalence and importance of pain/discomfort on ejaculation (prostatitis-like symptom) in men with lower urinary tract symptoms (LUTS) diagnosed with clinical benign prostatic hyperplasia (BPH).
Patients and methods: Baseline data from 5096 men reporting LUTS suggestive of BPH, and enrolled in the ALF-ONE study by general practitioners and urologists in Europe, Asia, Latin America, the Middle East and Canada, were analysed to determine the prevalence and significance of pain/discomfort on ejaculation. All the men were asked to complete the International Prostate Symptom Score (IPSS) questionnaire, the bother score (IPSS question 8), and the Danish Prostate Symptom Score sexual-function questionnaire (DAN-PSSsex) which assesses three symptoms (rigidity of erection, amount of ejaculate and pain/discomfort on ejaculation) and their bothersomeness.
Results: There were 3700 sexually active men who had an evaluable answer to the DAN-PSSsex question related to pain/discomfort on ejaculation. Of these, 688 (18.6%) reported pain/discomfort on ejaculation and 609 (88%) considered it was a problem. Patients with painful ejaculation had more severe LUTS and reported greater bother (P < 0.001). Of men with painful ejaculation, 72% reported erectile dysfunction, of whom 91% considered it a problem, and 75% reported reduced ejaculation, of whom 81% considered it a problem. By contrast, of men with no ejaculatory discomfort, 57% reported erectile dysfunction, of whom 79% considered it a problem, and 56% reported reduced ejaculation, of whom 57% considered it a problem. A history of urinary tract infection was reported by 12% of men in the ejaculatory pain group, compared with 7% in the LUTS-only group, while 5% of men in the ejaculatory pain group reported macroscopic haematuria, compared to 3% in the LUTS-only group. Men with ejaculatory pain were slightly younger, but there were no significant differences in duration of LUTS, history of acute urinary retention, prostate-specific antigen concentrations or maximum urinary flow rate compared to the LUTS-only group.
Conclusions: Of sexually active men with LUTS suggestive of BPH, approximately 20% complain of specific prostatitis-like symptoms of pain/discomfort on ejaculation, and these men clearly differ from those who present with LUTS only. For most the symptom is a significant bother. Men with BPH and painful ejaculation have more severe LUTS and reported greater bother, and had a higher prevalence of erectile dysfunction and reduced ejaculation, than men with LUTS only. Evaluation and treatment strategies should address this population of men with symptoms suggestive of both prostatitis and BPH.
Similar articles
-
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7. BJU Int. 2009. PMID: 19426189
-
The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.BJU Int. 2006 Jun;97(6):1242-6. doi: 10.1111/j.1464-410X.2006.06171.x. BJU Int. 2006. PMID: 16686719 Clinical Trial.
-
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.BJU Int. 2005 Mar;95(4):603-8. doi: 10.1111/j.1464-410X.2005.05347.x. BJU Int. 2005. PMID: 15705088 Clinical Trial.
-
Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x. BJU Int. 2005. PMID: 15871731 Review.
-
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.Clin Ther. 2006 Jan;28(1):13-25. doi: 10.1016/j.clinthera.2006.01.004. Clin Ther. 2006. PMID: 16490576 Review.
Cited by
-
An International Survey of Commonly Used Interventions for Management of Pelvic Pain.J Womens Health Phys Therap. 2019 Apr-Jun;43(2):82-88. doi: 10.1097/jwh.0000000000000131. J Womens Health Phys Therap. 2019. PMID: 32499673 Free PMC article.
-
Recent developments in diagnostic ultrasound for lower urinary tract function.J Med Ultrason (2001). 2024 Sep 27. doi: 10.1007/s10396-024-01494-0. Online ahead of print. J Med Ultrason (2001). 2024. PMID: 39327335 Review.
-
Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).J Endocrinol Invest. 2006 Jul-Aug;29(7):665-74. doi: 10.1007/BF03344169. J Endocrinol Invest. 2006. PMID: 16957418 Review.
-
Painful Ejaculation - An Ignored Symptom.Cureus. 2020 Oct 30;12(10):e11253. doi: 10.7759/cureus.11253. Cureus. 2020. PMID: 33269171 Free PMC article. Review.
-
The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome.Curr Urol Rep. 2012 Aug;13(4):263-7. doi: 10.1007/s11934-012-0254-0. Curr Urol Rep. 2012. PMID: 22580952 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous